March 22, 2024

Abstract 6395: Metabolic dysregulation as a determinant of prognosis and response to sorafenib in liver cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Background Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 6395.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Hyewon Park

Sowon Park

Sung-Hwan Lee

Journals

Cancer Research

Actions

Institutions

The University of Texas MD Anderson Cancer Center

Korea University

CHA Bundang Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Abstract 6395: Metabolic dysregulation as a determinant of prognosis and response to sorafenib in liver cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study